Satraplatin: an orally available platinum analog for the treatment of cancer.
about
Say No to DMSO: Dimethylsulfoxide Inactivates Cisplatin, Carboplatin, and Other Platinum ComplexesSystems biology of cisplatin resistance: past, present and futureSatraplatin: leading the new generation of oral platinum agentsUnusual DNA binding modes for metal anticancer complexes.Phase 1 trial and pharmacokinetic study of the oral platinum analog satraplatin in children and young adults with refractory solid tumors including brain tumors.Broadening the clinical use of platinum drug-based chemotherapy with new analogues. Satraplatin and picoplatin.Metallomics insights into the programmed cell death induced by metal-based anticancer compounds.A Quadruple-Action Platinum(IV) Prodrug with Anticancer Activity Against KRAS Mutated Cancer Cell Lines.Finely Tuned Asymmetric Platinum(IV) Anticancer Complexes: Structure-Activity Relationship and Application as Orally Available Prodrugs.Behavior of platinum(iv) complexes in models of tumor hypoxia: cytotoxicity, compound distribution and accumulation.Theoretical investigations and density functional theory based quantitative structure-activity relationships model for novel cytotoxic platinum(IV) complexes.Novel tetracarboxylatoplatinum(IV) complexes as carboplatin prodrugs.A fluorescent probe for investigating the activation of anticancer platinum(IV) prodrugs based on the cisplatin scaffold.Triple action Pt(iv) derivatives of cisplatin: a new class of potent anticancer agents that overcome resistance.
P2860
Q24289008-A11FF084-7189-4A45-A315-1808D48C36E0Q26863585-8385E012-99F7-40A7-A8F4-3394915BE935Q28972468-90D2A38B-5157-4D1E-9B9B-AFAC26466918Q34071185-4C8B68C6-7766-4FD1-A266-C0497E413A8CQ35118358-F1E4AFB2-8AA1-4F18-BBFA-C105629FFD8BQ36861592-EB6EFACF-404B-4EE1-A451-5AA25F459B8CQ38199383-04636761-86B5-41A6-9F69-90F401605C70Q38696069-95CA09D2-D76A-4991-8098-11D5E216E679Q38724009-E50074D0-B37C-4FF7-AF10-DD8CF2534B20Q38795441-B11DA705-CF17-4D51-849D-1FC35DE6B88EQ39231857-796DE2FA-6EBD-4B80-BEE8-07A9AE598947Q39298980-F5B2CB5B-D6AA-4042-A1B5-A4AD6AE62B07Q44320923-FBAF77CC-C74C-4C35-979E-0828F8C67755Q54108527-FE0E8EF9-DCFC-4AC4-88C0-6B07C363F373
P2860
Satraplatin: an orally available platinum analog for the treatment of cancer.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Satraplatin: an orally available platinum analog for the treatment of cancer.
@ast
Satraplatin: an orally available platinum analog for the treatment of cancer.
@en
type
label
Satraplatin: an orally available platinum analog for the treatment of cancer.
@ast
Satraplatin: an orally available platinum analog for the treatment of cancer.
@en
prefLabel
Satraplatin: an orally available platinum analog for the treatment of cancer.
@ast
Satraplatin: an orally available platinum analog for the treatment of cancer.
@en
P2860
P356
P1476
Satraplatin: an orally available platinum analog for the treatment of cancer.
@en
P2093
P2860
P304
P356
10.1586/14737140.6.7.973
P577
2006-07-01T00:00:00Z